SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Skybiotech Healthcare informs about outcome of board meeting

15 Nov 2025 Evaluate

In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 ('Listing Regulations'), Skybiotech Healthcare has informed that the Board of Directors at its meeting held on Friday, November 14, 2025, to considered and approved: 1. Un-Audited Financial Results (standalone and consolidated) for the half year ended September 30, 2025 and took on record the Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid Board Meeting commenced at 05:50 pm and concluded at 11:55 pm on November 14, 2025.

The above information is a part of company’s filings submitted to BSE.

Skybiotech Healthcar Share Price

138.90 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Welspun Living 133.75
Vardhman Textiles 580.60
Arvind 435.40
K.P.R. Mill 954.80
Page Industries 37326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×